Serotiny
San Francisco
About Serotiny
Serotiny is an AI-based platform that invents multi-domain therapeutic proteins for CAR T-cell therapies. It also helps in developing multi-domain proteins for cell therapies for the treatment of cancer and a genetic disorder.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $3.1M
- Funding stage: M&A
- Last round: Seed (Jul 2018)
- Website: serotiny.bio
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Bioinformatics, Biotechnology, Genetics, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/serotiny-142356 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.